SGA
UTHR icon

Strategic Global Advisors’s United Therapeutics UTHR Stock Holding History

Strategic Global Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,857
Closed -$1.16M – 165
2019
Q1 		$1.16M Buy
9,857
+1,795
+22% +$209K 0.24% 99
2018
Q4 		$878K Sell
8,062
-717
-8% -$83.1K 0.31% 70
2018
Q3 		$1.12M Sell
8,779
-1,211
-12% -$150K 0.34% 70
2018
Q2 		$1.12M Hold
9,990
– – 0.29% 74
2018
Q1 		$1.12M Hold
9,990
– – 0.38% 63
2017
Q4 		$1.48M Sell
9,990
-380
-4% -$48.3K 0.48% 52
2017
Q3 		$1.22M Buy
10,370
+151
+1% +$19.3K 0.47% 61
2017
Q2 		$1.33M Sell
10,219
-780
-7% -$97.3K 0.49% 54
2017
Q1 		$1.49M Sell
10,999
-983
-8% -$149K 0.54% 54
2016
Q4 		$1.72M Buy
11,982
+7,590
+173% +$969K 0.64% 46
2016
Q3 		$465K Buy
4,392
+2
+0% +$240 0.17% 108
2016
Q2 		$465K Hold
4,390
– – 0.18% 106
2016
Q1 		$489K Sell
4,390
-310
-7% -$39.2K 0.21% 99
2015
Q4 		$736K Buy
+4,700
New +$684K 0.31% 79

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Strategic Global Advisors's UTHR Position: Q2 2019 in Review

Strategic Global Advisors sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 9,857 shares — an estimated $1.16M sold.

Strategic Global Advisors first reported a position in UTHR in Q4 2015 and held it in 14 quarters. The position peaked at $1.72M in Q4 2016. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

  • Strategic Global Advisors reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Strategic Global Advisors sold 9,857 United Therapeutics shares in Q2 2019, an estimated $1.16M.
  • Strategic Global Advisors first reported a position in United Therapeutics in Q4 2015 and held it in 14 quarters.
  • Strategic Global Advisors's United Therapeutics position peaked at $1.72M in Q4 2016.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on Strategic Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.